Roche Wins Safe Harbor For Mircera Tests — For Now
An appeals court has ruled that Swiss pharmaceutical giant Roche Holding Ltd. can continue to develop anemia drug Mircera using processes allegedly patented by Amgen Inc. pending a closer look by...To view the full article, register now.
Already a subscriber? Click here to view full article